Clinical Trial: Use of a β-Glucan Cream in Incontinence-Associated Dermatitis

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07524439) titled 'Use of a β-Glucan Cream in Incontinence-Associated Dermatitis' on Jan. 29.

Brief Summary: The goal of this clinical trial is to learn if a topical 0.5% barley-derived β-glucan cream (Soothing Beta Cream, Dr. Mom) works to improve healing of incontinence-associated dermatitis (IAD) in hospitalized adults. The study will also learn about the safety and tolerability of the β-glucan cream when used along with standard skin care.

The main questions it aims to answer are:

Does adding β-glucan cream to standard care reduce the severity of IAD compared with standard care alone?

Does the β-glucan cream help IAD h...